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INTRODUCTION 
Everyone must have experienced pain at one point 
in their life. Pain can be a sign that something went 
wrong in our body. Pain is a complex perception, it 
varies from one person to another, even when they 
experienced relatively similar injury or illness. Pain 
does not only involve the perception of a sensation, 
but is also related to physiological, psychologi-
cal, social, cognitive, emotional, and behavioral 
responses, so that the management of pain requires 
serious attention from all elements involved in 
health services. That is why it is necessary for 
doctors to recognize and understand pain so that 
management goals can be maximally achieved.1-3
The International Association for the Study of Pain 
(IASP) first defined pain in 1979 as an unpleasant 
sensory and emotional experience associated with 
actual or potential tissue damage or described in 
terms of such damage.3 From the above definition, 
it can be concluded that pain is subjective for each 
individual, and they learn what pain is through their 
life experience from the beginning of their lifetime.
Unlike acute pain, chronic pain is more likely to 
show behavioral responses in the form of immobili-
zation, physical inactivity, withdrawal, and despair. 
Because there are no obvious symptoms and signs, 
diagnosing chronic pain is always a challenge for 
physicians.
Musculoskeletal pain disorders are often found 
in the population, like frozen shoulder, shoulder 
joint pain, elbow joint pain, knee osteoarthritis, 
piriformis syndrome, plantar fasciitis, postopera-
tive chronic pain, etc. The incidence of joint pain 
disease in Indonesia is 1-2% of the total population. 
In 2004, the number of joint pain patients reached 
2 million people, with 3:1 comparison between 
female and male. 
It was estimated that 1 in 6 people in the world 
suffers from joint pain.4 It is estimated that this 
number will keep increasing, and in 2025 more 
than 25% of them will experience paralysis. The 
World Health Organization (WHO) reports that 
20% of the world population is suffering from joint 
pain, where 5-10% aged 5-20 years, and 20% aged 
>55 years.4-6 
THE DEVELOPMENT OF PAIN 
MANAGEMENT
Pain management is not solely approached by 
prescribing drugs as known by the public. The 
biological processes that accompany the emergence 
of pain are so complex, and so is the management 
of pain.7 It involves several methods to cope with 
biological processes at each stage of pain so that an 
optimal result can be achieved. 
One method to approach the management 
of pain is a non-pharmacological approach. It 
consists of the use of behavioral therapy, relax-
ation, acupuncture, cognitive therapy (distraction), 
cognitive restructuring, imagination, and physical 
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Pain is a common complaint found in the population. Inadequate 
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cause new problems. Several medical intervention techniques with 
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area in Bali Island to alleviate their pain-associated symptoms and to 
introduce this minimally invasive pain management technique.
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therapy. The second method is the pharmacological 
approach. There are three main groups of drugs 
that are used to treat pain: opioids, non-opioids, 
and other pain-alleviating drugs that can act as 
adjuvants. The third one is the invasive approach. 
This includes surgical approach and non-surgical 
approach, or the minimally invasive interventional 
pain management.8-11
Pharmacological pain management is not risk-
free. Various risks from the use of pharmacological 
agents related to side effects that can arise may 
also lead to new problems. The long-term use of 
non-steroidal anti-inflammatory drugs (NSAIDs) 
may increase the risk of bleeding, gastric perfora-
tion, and gastric ulcers. In addition, long-term use 
of NSAIDs has also been shown to reduce blood 
flow to the kidneys so that it can increase the risk 
of kidney failure. While the use of analgesic narcot-
ics groups also has other risks that are also quite 
dangerous, which can be at risk of causing consti-
pation, respiratory depression, and has an additive 
effect that can cause drug abuse.12-14
In recent years various medical interventions 
have been successfully carried out.15-22 Medical 
intervention continues to be developed in order 
to effectively eliminate pain with minimal risks. 
Several medical intervention techniques with inva-
sive procedures for pain have also been performed, 
such as hydrodisectomy with ultrasound guidance. 
Hydrodisectomy is a minimally invasive outpa-
tient procedure that uses high-speed water flow to 
remove herniated tissue, removing pressure on the 
nerves that cause back and leg pain. 
A nerve block with local anesthetics and steroids 
have also been done.15-18,21,22 It can relieve pain 
through local effects without the need to burden 
the systemic and other body organs. It also includes 
invasive procedures that are usually performed by 
inserting local anesthetics with or without adjuvant 
into the epidural or subarachnoid space through the 
intraspinal or directly on the peripheral nerve site. 
This method can provide a strong analgesic effect 
with less dose. Other invasive procedures include 
nerve blocks, spinal stimulation, surgery (rhizot-
omy, cordotomy), or dorsal column stimulation. 
However, those advanced techniques are not 
familiar to many populations in Indonesia. Lack 
of knowledge and lack of information about the 
Indonesian population regarding these tech-
niques are perhaps the two most important factors 
contributing to this situation. We established a free 
of charge, medical service in a community health 
center in Blahkiuh subdistrict, at Abiansemal, 
Badung regency, located in the north of Denpasar. 
The goals of this service were to introduce mini-
mally invasive techniques to local people and to 
help those with chronic pain to gain some advan-
tages offered by this technique. 
THE COMMUNITY SERVICE
The service took place on September 20, 2018, from 
9 am to 4 pm, at Abiansemal Public Health Center 
of Badung Regency. Aside from clinical service, 
we also conducted presentation and discussion to 
the people attending the public health center about 
minimally invasive pain relieving techniques. In 
terms of medical service, we conducted minimally 
invasive technique to 52 patients needing pain 
alleviating service from medical providers, details 
displayed in Table 1. 
A most common finding in the subjects was 
osteoarthritis that was found in 15 subjects. Then 
followed by trapezius muscle spasm (8 subjects), 
and hernia nucleus pulposus (HNP), facet joint 
pain, and piriformis syndrome, with 5 subjects 
each. Medical interventions given was mainly pain 
killer medications, and minimally invasive pain 
relieving techniques was performed to 12 subjects. 
The detailed therapeutic technique chosen is 
displayed in Table 2.
Out of 52 patients given medical interventions, 
2  patients were given the recommendation to 
undergo a series of physiotherapy and 8 patients 
Table 1  Age, baseline blood pressure, and pain types of the 
patients
Variables N(%)
Age
<30 years old, n(%) 2
31-40 years old, n(%) 2
41-50 years old, n(%) 10
51-60 years old, n(%) 15
61-70 years old, n(%) 14
>70 years old, n(%) 12
Baseline blood pressure 
Normotension, n(%) 21
Pre-hypertension, n(%) 11
Hypertension grade I, n(%) 12
Hypertension grade II, n(%) 4
Pain types
Muscle pain 9
Joint pain 23
Neuropathic pain 15
Pain originating from tendines, ligament, and meniscus 3
Cystic pain 2
Others 3
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were asked to seek further medical service for further 
investigations. The subjects’ pain score before and 
after the treatment are displayed in Table 3. Based 
on a questionnaire given after the medical service 
of each patient, 96% of subjects were satisfied with 
the course of this medical service.
CONCLUSION
Conducting a simple program for a community that 
consists of the educational program, group-based 
discussion, and minimally invasive pain manage-
ment procedures may increase the knowledge of the 
community about pain and the available options to 
treat it. While a pain killer drugs are still common 
to be prescribed, it is important for the patients to 
know that there are other options available. This 
program not only introduced but also proved the 
efficacy of minimally invasive methods to the people 
affected by both acute and chronic pain. Similar 
programs will be upheld in the future to show our 
commitment to fighting pain in the community. 
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